Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 1, 2023
January 31, 2023
9dafe0c9-19d4-48c0-a1ca-6b2a04a813ed
Related Documents
Container Closure Systems for Human Drugs and Biological Products
Guidance DocumentAugust 13, 2026Center for Drug Evaluation and Research
Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice: Draft Guidance for Industry
Guidance DocumentSeptember 18, 2024Center for Drug Evaluation and Research
Real-World Evidence: Considerations Regarding Non-Interventional Studies for Drug and Biological Products
Guidance DocumentMarch 21, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.